Atorvastatin Calcium
Product Images NDC 68071-2468

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2468 3)

Pdp (68071 2468 3)
Label for Atorvastatin Calcium 40mg tablets by NuCare Pharmaceuticals, Inc., showing a package of 30 tablets. The label includes NDC 68071-2468-3, indicates the product is Rx Only, and notes the tablets are white to off-white, oval-shaped, debossed with "FF3" on one side. Manufacturer information and storage instructions are also displayed.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

Figure (Atorvastatin Calcium Figure 1)
A line graph comparing the cumulative incidence percentage over time in years between Atorvastatin and placebo groups. The x-axis represents years from 0 to 3.5, and the y-axis represents cumulative incidence percentage from 0.0 to 4.0%. The graph includes a hazard ratio (HR) of 0.64 with a 95% confidence interval (0.50-0.83) and a p-value of 0.0005, indicating the statistical comparison between groups.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
A line graph showing cumulative hazard percentage over time in years for Atorvastatin compared to placebo. The x-axis represents time to first primary endpoint through four years of follow-up; the y-axis shows cumulative hazard percentage. Two lines represent the placebo (dashed) and Atorvastatin (solid). Hazard ratio and p-value are also displayed.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
A Kaplan-Meier curve comparing the proportion of subjects experiencing a major cardiovascular event over 5 years for Atorvastatin 10 mg (dashed line) versus Atorvastatin 80 mg (solid line). The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The chart includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical Structure (Atorvastatin Calcium Structure)
Chemical structure of atorvastatin calcium, illustrating the molecular arrangement of atoms, including fluorophenyl groups, hydroxyl groups, and calcium ions, consistent with atorvastatin calcium trihydrate as shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.